Table 3.

TNBC patient risk groups stratified by EGFR and SUVmax (with the median values of variables)

Risk groups (EGFR > 15, SUVmax > 3.5)	Patient#	DFS months	EGFR  %	SUVmax	SUVmean	SUVvol (ml)	Path. T stage	CK5/6 %	Ki-67  %
1 (−, −)	12	22.8	5.0	2.0	0.6	0.3	1.8	4.5	34.5
2 (−, +)	15	17.2	5.0	8.9	4.3	7.2	2.0	5.0	67.0
3 (+, −)	13	11.6	50.0	2.7	2.6	0.9	1.8	5.0	35.0
4 (+, +)	37	7.6	60.0	11.3	5.2	10.9	2.0	20.0	60.0